Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 11, 2022
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
[ Tue, Jan 11th 2022
] - WOPRAI
Mon, January 10, 2022
[ Mon, Jan 10th 2022
] - WOPRAI
[ Mon, Jan 10th 2022
] - WOPRAI
[ Mon, Jan 10th 2022
] - WOPRAI
[ Mon, Jan 10th 2022
] - WOPRAI
Michael King Initiated (XLO) at Strong Buy and Held Target at $36 on, Jan 10th, 2022
Michael King of HC Wainwright & Co., Initiated "Xilio Therapeutics, Inc." (XLO) at Strong Buy and Held Target at $36 on, Jan 10th, 2022.
Michael has made no other calls on XLO in the last 4 months.
There are 3 other peers that have a rating on XLO. Out of the 3 peers that are also analyzing XLO, 0 agree with Michael's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Michael
- Dane Leone of "Raymond James" Initiated at Buy and Held Target at $31 on, Tuesday, November 16th, 2021
- Marc Frahm of "Cowen & Co." Initiated at Buy on, Tuesday, November 16th, 2021
- Michael Ulz of "Morgan Stanley" Initiated at Buy and Held Target at $32 on, Tuesday, November 16th, 2021
